InVision™ ctDNA liquid biopsy platform to be used to inform therapy following surgery of curative intent Addario Lung Cancer Medical Research Institute (ALCMI), a patient-founded not-for-profit global research consortium, and Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid ...
Read More »Exosome Diagnostics and the Addario Lung Cancer Medical Institute (ALCMI) to Collaborate on Development of Liquid Biopsy Cancer Diagnostics
Clinical testing underway utilizing matched samples from ALCMI’s Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Trial Collaboration will support validation for Exosome Diagnostics’ ALK and T790M plasma-based diagnostics planned to launch in 2015 Novel biofluid-based diagnostics offer the potential to ...
Read More »